Molecular Imaging

Molecular imaging (also called nuclear medicine or nuclear imaging) can image the function of cells inside the body at the molecular level. This includes the imaging modalities of positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. How does PET and SPECT imaging work? Small amounts of radioactive material (radiopharmaceuticals) injected into a patient. These can use sugars or chemical traits to bond to specific cells. The radioactive material is taken up by cells that consume the sugars. The radiation emitted from inside the body is detected by photon detectors outside the body. Computers take the data to assemble images of the radiation emissions. Nuclear images may appear fuzzy or ghostly rather than the sharper resolution from MRI and CT.  But, it provides metabolic information at a cellular level, showing if there are defects in the function of the heart, areas of very high metabolic activity associated with cancer cells, or areas of inflammation, data not available from other modalities. These noninvasive imaging exams are used to diagnose cancer, heart disease, Alzheimer’s and Parkinson’s disease, bone disorders and other disorders. 

Computed Tomography

No matter how you slice it, CT vendors have continued to push the design and image quality of today's scanners, improving their overall clinical performance and increasing anatomical coverage. To no one's surprise, multi-detector CT continued the buzz it

New leadership for GE Healthcare's molecular imaging business

GE Healthcare last week announced that Jean-Luc Vanderheyden has been named to the newly created position of leader for the company's Molecular Imaging business.

IDC ranks 104th in the 2005 Deloitte Technology Fast 500

IDC (Imaging Dynamics Company) ranks Number 104 on the 2005 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America.

AMICAS ranks high in KLAS, with customers

AMICAS Inc. is ranked second in overall performance among all PACS providers in the acute care space for 2005, as measured by KLAS.

Harvard researchers use Gamma Medica-Ideas CT to detect early lung cancer

Researchers at Harvard Medical School are using a Gamma Medica-Ideas FLEX CT system to develop methods for early cancer detection.

PET-CT & SPECT-CT: With Fusion Comes Clarity

Fusion imaging is proving itself in faster diagnosis, better treatment decisions, and better patient outcomes. Both PET-CT and SPECT-CT are growing in applications and volume.

Brailer says: The time for action has begun

Use of the EHR is absolutely inevitable, said Daivd Brailer, PhD, MD, national coordinator for health information technology.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup